Cephaloglycin - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for cephaloglycin and what is the scope of patent protection?
Cephaloglycin
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for cephaloglycin
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 25 |
Patent Applications: | 4,958 |
DailyMed Link: | cephaloglycin at DailyMed |
Medical Subject Heading (MeSH) Categories for cephaloglycin
US Patents and Regulatory Information for cephaloglycin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | KAFOCIN | cephaloglycin | CAPSULE;ORAL | 050219-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |